171 related articles for article (PubMed ID: 21645562)
1. Development of recombinant rabies viruses vectors with Gaussia luciferase reporter based on Chinese vaccine strain CTN181.
Du J; Tang Q; Huang Y; Rodney WE; Wang L; Liang G
Virus Res; 2011 Sep; 160(1-2):82-8. PubMed ID: 21645562
[TBL] [Abstract][Full Text] [Related]
2. [Construction and recovery of chimeric rabies virus expressing envelop proteins E1E2 of hepatitis C].
Du JL; Huang Y; Tang Q; Wang LH; Liang GD
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Jun; 25(3):170-2. PubMed ID: 21977582
[TBL] [Abstract][Full Text] [Related]
3. Development of EGFP/GLUC-tagged Sindbis-like virus XJ-160.
Wuyang Z; Li J; Wang H; He Y; Liang G
J Virol Methods; 2013 Apr; 189(1):235-7. PubMed ID: 23403149
[TBL] [Abstract][Full Text] [Related]
4. Development of a reverse genetics system for a human rabies virus vaccine strain employed in China.
Huang Y; Tang Q; Nadin-Davis SA; Zhang S; Hooper CD; Ming P; Du J; Tao X; Hu R; Liang G
Virus Res; 2010 Apr; 149(1):28-35. PubMed ID: 20080136
[TBL] [Abstract][Full Text] [Related]
5. Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene.
Cenna J; Tan GS; Papaneri AB; Dietzschold B; Schnell MJ; McGettigan JP
Vaccine; 2008 Nov; 26(50):6405-14. PubMed ID: 18804506
[TBL] [Abstract][Full Text] [Related]
6. Dominance of a nonpathogenic glycoprotein gene over a pathogenic glycoprotein gene in rabies virus.
Faber M; Faber ML; Li J; Preuss MA; Schnell MJ; Dietzschold B
J Virol; 2007 Jul; 81(13):7041-7. PubMed ID: 17459937
[TBL] [Abstract][Full Text] [Related]
7. Development of a stable Gaussia luciferase enterovirus 71 reporter virus.
Xu LL; Shan C; Deng CL; Li XD; Shang BD; Ye HQ; Liu SQ; Yuan ZM; Wang QY; Shi PY; Zhang B
J Virol Methods; 2015 Jul; 219():62-66. PubMed ID: 25843263
[TBL] [Abstract][Full Text] [Related]
8. Generation of a novel live rabies vaccine strain with a high level of safety by introducing attenuating mutations in the nucleoprotein and glycoprotein.
Nakagawa K; Nakagawa K; Omatsu T; Katayama Y; Oba M; Mitake H; Okada K; Yamaoka S; Takashima Y; Masatani T; Okadera K; Ito N; Mizutani T; Sugiyama M
Vaccine; 2017 Oct; 35(42):5622-5628. PubMed ID: 28882441
[TBL] [Abstract][Full Text] [Related]
9. Development of a Gaussia luciferase-based human norovirus protease reporter system: cell type-specific profile of Norwalk virus protease precursors and evaluation of inhibitors.
Qu L; Vongpunsawad S; Atmar RL; Prasad BV; Estes MK
J Virol; 2014 Sep; 88(18):10312-26. PubMed ID: 25008934
[TBL] [Abstract][Full Text] [Related]
10. Development and characterization of West Nile virus replicon expressing secreted Gaussia luciferase.
Shan C; Li X; Deng C; Shang B; Xu L; Ye H; Yuan Z; Zhang B
Virol Sin; 2013 Jun; 28(3):161-6. PubMed ID: 23709059
[TBL] [Abstract][Full Text] [Related]
11. Study on an attenuated rabies virus strain CTN181-3.
Shi L; Zou J; Li Y; Yu Y
Biologicals; 2022 Jul; 78():10-16. PubMed ID: 35786353
[TBL] [Abstract][Full Text] [Related]
12. A reporter system for assaying influenza virus RNP functionality based on secreted Gaussia luciferase activity.
Zhu W; Zhou J; Qin K; Du N; Liu L; Yu Z; Zhu Y; Tian W; Wu X; Shu Y
Virol J; 2011 Jan; 8():29. PubMed ID: 21251302
[TBL] [Abstract][Full Text] [Related]
13. Biological and immunogenic properties of rabies virus glycoprotein expressed by canine herpesvirus vector.
Xuan X; Tuchiya K; Sato I; Nishikawa Y; Onoderaz Y; Takashima Y; Yamamoto A; Katsumata A; Iwata A; Ueda S; Mikami T; Otsuka H
Vaccine; 1998; 16(9-10):969-76. PubMed ID: 9682345
[TBL] [Abstract][Full Text] [Related]
14. [The function of helper plasmids from HEP-Flury strain rabies virus on encapsidating the full-length genome of CTN strain].
Huang Y; Tang Q; Hu RL
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 May; 30(5):493-6. PubMed ID: 19799148
[TBL] [Abstract][Full Text] [Related]
15. [Development and Identification of the Recombinant Lentivirus Co-expressing HCV Structural Protein and Secreted Gaussia Luciferase (Gluc)].
Zhang L; Liu X; Song J; Xin Y; Deng Y; Tan W
Bing Du Xue Bao; 2015 Mar; 31(2):174-9. PubMed ID: 26164944
[TBL] [Abstract][Full Text] [Related]
16. Rabies vaccine development by expression of recombinant viral glycoprotein.
Astray RM; Jorge SA; Pereira CA
Arch Virol; 2017 Feb; 162(2):323-332. PubMed ID: 27796547
[TBL] [Abstract][Full Text] [Related]
17. Feline herpesvirus vectored-rabies vaccine in cats: A dual protection.
Chen T; Zhou X; Qi Y; Mi L; Sun X; Zhang S; Liu Y; Olson V; Qiu W; Wu X; Hu R
Vaccine; 2019 Apr; 37(16):2224-2231. PubMed ID: 30878247
[TBL] [Abstract][Full Text] [Related]
18. Construction and characterization of recombinant senecavirus A expressing secreted luciferase for antiviral screening.
Wang H; Mo Y; Liu W; He Q; Ren T; Ouyang K; Chen Y; Huang W; Wei Z
J Virol Methods; 2024 Jun; 327():114932. PubMed ID: 38582378
[TBL] [Abstract][Full Text] [Related]
19. Molecular basis of neurovirulence of flury rabies virus vaccine strains: importance of the polymerase and the glycoprotein R333Q mutation.
Tao L; Ge J; Wang X; Zhai H; Hua T; Zhao B; Kong D; Yang C; Chen H; Bu Z
J Virol; 2010 Sep; 84(17):8926-36. PubMed ID: 20538851
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a single-cycle rabies virus-based vaccine vector.
Gomme EA; Faul EJ; Flomenberg P; McGettigan JP; Schnell MJ
J Virol; 2010 Mar; 84(6):2820-31. PubMed ID: 20053743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
